Revolutionizing the manufacturing, storage, and delivery of vaccines and biologics
Jurata's thermostabilizing formulations enable the long-term storage of vaccines and biologics at ambient or elevated temperatures. Therapeutic cargo stored in our films can be administered via various routes.
We aim to make vaccines and therapeutics more accessible and easily administered to people throughout the world.
Our team includes expertise and experience in designing cutting edge technologies and bringing them to the clinic.
Meet the Winners. Jurata Thin Film awarded 3rd place at the 2024 Hello Tomorrow Global Challenge.
Empowering Under-the-tongue Vaccine Delivery. CEPI to provide up to $1.2 million to Jurata to develop under-the-tongue films for mRNA-LNP vaccine delivery.
Chapel Hill's Jurata. Jurata Thin Film aims to revolutionize drug delivery by slipping a film inside the cheek or under the tongue.
No Need for Cold Chain. Most vaccines and biologics must stay cold until ready for use, but new thin film technology stabilizes these therapeutics for months at room temperature.
No more needles? Imagine receiving a COVID-19 vaccine not from the jab of a needle and syringe but by slipping a thin, clear film smaller than a postage stamp inside your cheek or under your tongue and letting it dissolve.
Access to Capital and Innovation in Biotech. CEO and Co-Founder, Sheila Mikhail, talks on Nasdaq's Breakthrough Economy series to discuss Jurata's technology, biotech incubators, and diversity in industry.
If you are interested in learning more about our technology or partnering with our company, please contact us using the link below.
Jurata Thin Film, Inc.
Houston, Texas, USA
Copyright © 2024 Jurata Thin Film - All Rights Reserved.
